Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $413.73 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $84.79 | 6 | $0 (2019) |
| Heidelberg Engineering, Inc. | $63.02 | 1 | $0 (2017) |
| Allergan Inc. | $60.81 | 4 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $52.92 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $39.23 | 3 | $0 (2020) |
| Kala Pharmaceuticals, Inc. | $25.39 | 1 | $0 (2020) |
| Shire North American Group Inc | $24.44 | 1 | $0 (2017) |
| CooperVision Inc. | $18.26 | 1 | $0 (2018) |
| Omeros Corporation | $16.38 | 1 | $0 (2019) |
| Alcon Vision LLC | $15.10 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $37.10 | 2 | Kala Pharmaceuticals, Inc. ($25.39) |
| 2019 | $139.26 | 10 | Bausch & Lomb, a division of Bausch Health US, LLC ($56.17) |
| 2018 | $114.36 | 8 | Allergan Inc. ($39.22) |
| 2017 | $123.01 | 4 | Heidelberg Engineering, Inc. ($63.02) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/10/2020 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: OCULAR | ||||||
| 02/07/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/20/2019 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: Ophthalmology | ||||||
| 11/12/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), ZYLET, BESIVANCE | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/22/2019 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug), BROMSITE | Food and Beverage | Cash or cash equivalent | $12.87 | General |
| Category: Ophthalmology | ||||||
| 08/10/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/08/2019 | Alcon Vision LLC | ACTIVEFOCUS (Device) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Ophthalmology | ||||||
| 06/05/2019 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: Ophthalmology | ||||||
| 05/20/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/27/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Glaucoma | ||||||
| 02/13/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/10/2019 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug), BROMSITE | Food and Beverage | Cash or cash equivalent | $11.06 | General |
| Category: Ophthalmology | ||||||
| 12/11/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/19/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/19/2018 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/16/2018 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/01/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/09/2018 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/13/2018 | CooperVision Inc. | Clariti Contact Lens (Device) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Devices | ||||||
| 01/05/2018 | Sun Pharmaceutical Industries Inc. | BromSite (bromfenac ophthalmic solution) 0.075% (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Ophthalmology | ||||||
| 09/07/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: OPTHALMICS | ||||||
| 07/18/2017 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: DRY EYE | ||||||
| 05/08/2017 | Heidelberg Engineering, Inc. | Spectralis (Device) | Food and Beverage | In-kind items and services | $63.02 | General |
| Category: Ophthalmology Imaging Equipment | ||||||
| 03/06/2017 | Novartis Pharmaceuticals Corporation | ILEVRO (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 5 | 297 | 314 | $40,570 | $15,080 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 154 | 155 | $22,185 | $9,168 | 41.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 73 | $6,055 | $2,785 | 46.0% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 38 | 40 | $4,800 | $1,364 | 28.4% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 17 | 17 | $2,890 | $1,250 | 43.2% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 29 | 29 | $4,640 | $512.94 | 11.1% |
About Dr. Marc Young, MD
Dr. Marc Young, MD is a Ophthalmology healthcare provider based in Collingswood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083706808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Young, MD has received a total of $413.73 in payments from pharmaceutical and medical device companies, with $37.10 received in 2020. These payments were reported across 24 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($413.73).
As a Medicare-enrolled provider, Young has provided services to 297 Medicare beneficiaries, totaling 314 services with total Medicare billing of $15,080. Data is available for 1 year (2020–2020), covering 5 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Collingswood, NJ
- Active Since 09/29/2006
- Last Updated 07/08/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083706808
Products in Payments
- Spectralis (Device) $63.02
- XIIDRA (Drug) $36.15
- VYZULTA (Drug) $29.10
- BESIVANCE (Drug) $28.79
- INVELTYS (Drug) $25.39
- LUMIGAN (Drug) $24.78
- XELPROS (Drug) $23.93
- RESTASIS (Drug) $21.59
- Clariti Contact Lens (Device) $18.26
- Omidria (Drug) $16.38
- ACTIVEFOCUS (Device) $15.10
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $14.70
- COMBIGAN (Drug) $14.44
- BROMSITE (Drug) $14.29
- ILEVRO (Drug) $13.96
- PROLENSA (Drug) $13.64
- DUREZOL (Drug) $13.56
- Rhopressa (Drug) $13.39
- LOTEMAX SM (Drug) $13.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.